Regulation of the immune system by NF-κB and IκB

Journal of Biochemistry and Molecular Biology

Volumn 35, Issue 6, 2002, Pages 537-546

  Liou, Hsiou Chi ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

I B; NF B

Indexed keywords

ALLERGEN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL; BIOLOGICAL MODEL; CELL COMMUNICATION; CELL DIVISION; CELL SURVIVAL; HUMAN; IMMUNE SYSTEM; METABOLISM; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ALLERGENS; ANIMALS; CELL COMMUNICATION; CELL DIVISION; CELL SURVIVAL; HUMANS; I-KAPPA B PROTEINS; IMMUNE SYSTEM; MODELS, BIOLOGICAL; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 0042539166     PISSN: 12258687     EISSN: 12258687     Source Type: Journal    
DOI: 10.5483/bmbrep.2002.35.6.537     Document Type: Review

References (96)

1. Akira, S., Takeda, K. and Kaisho, T. (2001) Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2, 675-680.
2. Alcamo, E., Mizgerd, J. P., Horwitz, B. H., Bronson, R., Beg, A. A., Scott, M., Doerschuk, C. M., Hynes, R. O. and Baltimore, D. (2001) Targeted mutation of TNF receptor I rescues the RelA-deficient mouse and reveals a critical role for NF-kappa B in leukocyte recruitment. J. Immunol. 167, 1592-1600.
3. Andjelic, S., Hsia, C., Suzuki, H., Kadowaki, T., Koyasu, S. and Liou, H. C. (2000) Phosphatidylinositol 3-kinase and NF-kappa B/Rel are at the divergence of CD40-mediated proliferation and survival pathways. J. Immunol. 165, 3860-3867.
4. Beg, A. A. and Baltimore, D. (1996) An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 274, 782-784.
5. Beg, A. A., Sha, W. C., Bronson, R. T. and Baltimore, D. (1995a) Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice. Genes Dev. 9, 2736-2746.
6. Beg, A. A., Sha, W. C., Bronson, R. T., Ghosh, S. and Baltimore, D. (1995b) Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature. 376, 167-170.
7. Ben-Neriah, Y. (2002) Regulatory functions of ubiquitination in the immune system. Nat. Immunol. 3, 20-26.
8. Benschop, R. J. and Cambier, J. C. (1999). B cell development: signal transduction by antigen receptors and their surrogates. Curr. Opin. Immunol. 11, 143-151.
9. Beutler, B. (2002) Toll-like receptors: how they work and what they do. Curr. Opin. Hematol. 9, 2-10.
10. Beutler, B., Du, X. and Poltorak, A. (2001) Identification of Toll-like receptor 4 (Tlr4) as the sole conduit for LPS signal transduction: genetic and evolutionary studies. J. Endotoxin. Res. 7, 277-280.
11. Botchkina, G. I., Geimonen, E., Bilof, M. L., Villarreal, O. and Tracey, K. J. (1999) Loss of NF-kappaB activity during cerebral ischemia and TNF cytotoxicity. Mol. Med. 5, 372-381.
12. Burkly, L., Hession, C., Ogata, L., Reilly, C., Marconi, L. A., Olson, D., Tizard, R., Cate, R. and Lo, D. (1995) Expression of relB is required for the development of thymic medulla and dendritic cells. Nature 373, 531-536.
13. Caamano, J. and Hunter, C. A. (2002) NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions. Clin. Microbiol. Rev. 15, 414-429.
14. Caamano, J. H., Rizzo, C. A., Durham, S. K., Barton, D. S., Raventos-Suarez, C., Snapper, C. M. and Bravo, R. (1998) Nuclear factor (NF)-kappa B2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. J. Exp. Med. 187, 185-196.
15. Cariappa, A., Liou, H. C., Horwitz, B. H. and Pillai, S. (2000) Nuclear factor kappa B is required for the development of marginal zone B lymphocytes. J. Exp. Med. 192, 1175-1182.
16. Cheng, P. C., Cherukuri, A., Dykstra, M., Malapati, S., Sproul, T., Chen, M. R. and Pierce, S. K. (2001) Floating the raft hypothesis: the roles of lipid rafts in B cell antigen receptor function. Semin. Immunol. 13, 107-114.
17. Craxton, A., Jiang, A., Kurosaki, T. and Clark, E. A. (1999) Syk and Bruton's tyrosine kinase are required for B cell antigen receptor-mediated activation of the kinase Akt. J. Biol. Chem. 274, 30644-30650.
18. Devin, A., Lin, Y., Yamaoka, S., Li, Z., Karin, M. and Liu, Z. (2001). The alpha and beta subunits of IkappaB kinase (IKK) mediate TRAF2- dependent IKK recruitment to tumor necrosis factor (TNF) receptor 1 in response to TNF. Mol. Cell Biol. 21, 3986-3994.
19. Doi, T. S., Marino, M. W., Takahashi, T., Yoshida, T., Sakakura, T., Old, L. J. and Obata, Y. (1999) Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality. Proc. Natl. Acad. Sci. USA 96, 2994-2999.
20. Donovan, C. E., Mark, D. A., He, H. Z., Liou, H. C., Kobzik, L., Wang, Y., De Sanctis, G. T., Perkins, D. L. and Finn, P. W. (1999) NF-kappa B/Rel transcription factors: c-Rel promotes airway hyperresponsiveness and allergic pulmonary inflammation. J. Immunol. 163, 6827-6833.
21. Dudley, E., Hornung, F., Zheng, L., Scherer, D., Ballard, D. and Lenardo, M. (1999) NF-kappaB regulates Fas/APO-1/CD95-and TCR- mediated apoptosis of T lymphocytes. Eur. J. Immunol. 29, 878-886.
22. Franzoso, G., Bours, V., Park, S., Tomita-Yamaguchi, M., Kelly, K. and Siebenlist, U. (1992) The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-κB-mediated inhibition. Nature 359, 339-342.
23. Franzoso, G., Carlson, L., Poljak, L., Shores, E. W., Epstein, S., Leonardi, A., Grinberg, A., Tran, T., Scharton-Kersten, T., Anver, M., Love, P., Brown, K. and Siebenlist, U. (1998) Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J. Exp. Med. 187, 147-159.
24. Fruman, D. A., Snapper, S. B., Yballe, C. M., Alt, F. W. and Cantley, L. C. (1999) Phosphoinositide 3-kinase knockout mice: role of p85alpha in B cell development and proliferation. Biochem. Soc. Trans. 27, 624-629.
25. Fujita, T., Nolan, G. P., Liou, H.-C., Scott, M. L. and Baltimore, D. (1993) The candidate proto-oncogene bcl-3 encodes a transcriptional co-activator that activates NF-κB p50 homodimers. Genes & Dev. 7, 1354-1363.
26. Gerondakis, S., Strasser, A., Metcalf, D., Grigoriadis, G., Scheerlinck, J. Y. and Grumont, R. J. (1996) Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor. Proc. Natl. Acad. Sci. USA 93, 3405-3409.
27. Ghosh, S. and Karin, M. (2002) Missing pieces in the NF-kappaB puzzle. Cell 109 (Suppl), S81-96.
28. Glimcher, L. H. (2001) Lineage commitment in lymphocytes: controlling the immune response. J. Clin. Invest. 108, s25-s30.
29. Grossmann, M., Metcalf, D., Merryfull, J., Beg, A., Baltimore, D. and Gerondakis, S. (1999) The combined absence of the transcription factors Rel and RelA leads to multiple hemopoietic cell defects. Proc. Natl. Acad. Sci. USA 96, 11848-11853.
30. Grossmann, M., Nakamura, Y., Grumont, R. and Gerondakis, S. (1999). New insights into the roles of ReL/NF-kappa B transcription factors in immune function, hemopoiesis and human disease. Int. J. Biochem. Cell. Biol. 31, 1209-1219.
31. Grossmann, M., O'Reilly, L. A., Gugasyan, R., Strasser, A., Adams, J. M. and Gerondakis, S. (2000) The anti-apoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression. Embo. J. 19, 6351-6360.
32. Grumont, R. J., Rourke, I. J., O'Reilly, L. A., Strasser, A., Miyake, K., Sha, W. and Gerondakis, S. (1998) B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells. J. Exp. Med. 187, 663-674.
33. Guttridge, D. C., Albanese, C., Reuther, J. Y., Pestell, R. G. and Baldwin, A. S., Jr. (1999) NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell Biol. 19, 5785-5799.
34. Hinz, M., Krappmann, D., Eichten, A., Deder, A., Scheidereit, C. and Strauss, M. (1999) NF-κB function in growth contril: regulation of cyclin D1 expression and G0/G1 to S-phase transition. Mol. Cell. Biol. 19, 2690-2698.
35. Hinz, M., Loser, P., Mathas, S., Krappmann, D., Dorken, B. and Scheidereit, C. (2002) Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells.
36. Hinz, M., Loser, P., Mathas, S., Krappmann, D., Dorken, B. and Scheidereit, C. (2001) Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells. Blood 97, 2798-2807.
37. Horwitz, B. H., Scott, M. L., Cherry, S. R., Bronson, R. T. and Baltimore, D. (1997) Failure of lymphopoiesis after adoptive transfer of NF-kappaB-deficient fetal liver cells. Immunity 6, 765-772.
38. Horwitz, B. H., Zelazowski, P., Shen, Y., Wolcott, K. M., Scott, M. L., Baltimore, D. and Snapper, C. M. (1999) The p65 subunit of NF-kappa B is redundant with p50 during B cell proliferative responses, and is required for germline CH transcription and class switching to IgG3. J. Immunol. 162, 1941-1946.
39. Hsia, C. Y., Cheng, S., Owyang, A. M., Dowdy, S. F. and Liou, H. C. (2002) c-Rel regulation of the cell cycle in primary mouse B lymphocytes. Int. Immunol. 14, 905-916.
40. Hsu, S. C., Gavrilin, M. A., Lee, H. H., Wu, C. C., Han, S. H., and Lai, M. Z. (1999) NF-kappa B-dependent Fas ligand expression. Eur. J. Immunol. 29, 2948-2956.
41. Huber, M. A., Denk, A., Peter, R. U., Weber, L., Kraut, N. and Wirth, T. (2002) The IKK-2/Ikappa Balpha /NF-kappa B pathway plays a key role in the regulation of CCR3 and eotaxin-1 in fibroblasts. A critical link to dermatitis in Ikappa Balpha -deficient mice. J. Biol. Chem. 277, 1268-1275.
42. Iotsova, V., Caamano, J., Loy, J., Yang, Y., Lewin, A. and Bravo, R. (1997) Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat. Med. 3, 1285-1289.
43. Karin, M. and Delhase, M. (2000) The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Semin. Immunol. 12, 85-98.
44. Kasibhatla, S., Genestier, L. and Green, D. R. (1999) Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor kappaB. J. Biol. Chem. 274, 987-992.
45. King, L. B., Norvell, A. and Monroe, J. G. (1999) Antigen receptor-induced signal transduction imbalance associated with the negative selection of immature B cells. J. Immunol. 162, 2655-2662.
46. Kontgen, F., Grumont, R. J., Strasser, A., Metcalf, D., Li, R., Tarlinton, D. and Gerondakis, S. (1995) Mice lacking the c-rel proto-oncogene exhibit defects in lymhocyte proliferation, humoral immunity, and interleukin-2 expression. Genes & Dev. 9, 1965-1977.
47. Krappmann, D., Patke, A., Heissmeyer, V. and Scheidereit, C. (2001) B-cell receptor- and phorbol ester-induced NF-kappaB and c-Jun N- terminal kinase activation in B cells requires novel protein kinase C's. Mol. Cell. Biol. 21, 6640-6650.
48. Krappmann, D. and Scheidereit, C. (1997) Regulation of NF-kappa B activity by I kappa B alpha and I kappa B beta stability. Immunobiology 198, 3-13.
49. Lee, H. H., Dadgostar, H., Cheng, Q., Shu, J. and Cheng, G. (1999) NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proc. Natl. Acad. Sci. USA 96, 9136-9141.
50. Li, Z. W., Chu, W., Hu, Y., Delhase, M., Deerinck, T., Ellisman, M., Johnson, R. and Karin, M. (1999) The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J. Exp. Med. 189, 1839-1845.
51. Liou, H.-C., Jin, Z., Tumang, J., Andjelic, S., Smith, K. A. and Liou, M.-L. (1999) C-Rel is crucial for lymphocyte proliferation but dispensable for T cell effector function. Int. Immunol. 11.
52. Liou, H.-C., Nolan, G. P., Ghosh, S., Fujita, T. and Baltimore, D. (1992) The NF-κB p50 precursor, p105, contains an internal IκB-like inhibitor that preferentially inhibits p50. EMBO J. 11, 3003-3009.
53. Liou, H.-C., Sha, W. C., Scott, M. L. and Baltimore, D. (1994) Sequential induction of NF-κB/Rel family proteins during B-cell terminal differentiation. Mol. Cell Biol. 14, 5349-5359.
54. Malek, S., Chen, Y., Huxford, T. and Ghosh, G. (2001) IkappaBbeta, but not IkappaBalpha, functions as a classical cytoplasmic inhibitor of NF-kappaB dimers by masking both NF-kappaB nuclear localization sequences in resting cells. J. Biol. Chem. 276, 45225-45235.
55. Marshall, A. J., Niiro, H., Yun, T. J. and Clark, E. A. (2000) Regulation of B-cell activation and differentiation by the phosphatidylinositol 3-kinase and phospholipase Cgamma pathway. Immunol. Rev. 176, 30-46.
56. Martin, P., Duran, A., Minguet, S., Gaspar, M. L., Diaz-Meco, M. T., Rennert, P., Leitges, M. and Moscat, J. (2002) Role of zeta PKC in B-cell signaling and function. Embo J. 21, 4049-4057.
57. Monroe, J. G. (2000) B-cell antigen receptor signaling in immature-stage B cells: integrating intrinsic and extrinsic signals. Curr Top Microbiol Immunol 245, 1-29.
58. Naumann, M., Nieters, A., Hatada, E. N., and Scheidereit, C. (1993). NF-kappa B precursor p100 inhibits nuclear translocation and DNA binding of NF-kappa B/rel-factors. Oncogene 8, 2275-2281.
59. Nolan, G. P., Fujita, T., Bhatia, K., Huppi, C., Liou, H.-C., Scott, M. and Baltimore, D. (1993) The bcl-3 proto-oncogene is nuclear-resident IκB that associatively regulates NF-κB p50 activity. Mol. Cell Biol. 13, 3557-3566.
60. Ouaaz, F., Arron, J., Zheng, Y., Choi, Y., and Beg, A. A. (2002). Dendritic cell development and survival require distinct NF-kappaB subunits. Immunity 16, 257-70.
61. Owyang, A. M., Tumang, J. R., Schram, B. R., Hsia, C. Y., Behrens, T. W., Rothstein, T. L. and Liou, H. C. (2001) c-Rel is required for the protection of B cells from antigen receptor-mediated, but not Fas-mediated, apoptosis. J. Immunol. 167, 4948-4956.
62. Pahan, K. and Schmid, M. (2000) Activation of nuclear factor-κB in the spinal cord of experimental allergic encephalomyelitis. Neurosci. Lett. 287, 17-20.
63. Phelps, C. B., Sengchanthalangsy, L. L., Huxford, T. and Ghosh, G. (2000) Mechanism of I kappa B alpha binding to NF-kappa B dimers. J. Biol. Chem. 275, 29840-29846.
64. Pizzi, M., Goffi, F., Boroni, F., Benarese, M., Perkins, S. E., Liou, H. C. and Spano, P. (2002) Opposing roles for NF-kappa B/Rel factors p65 and c-Rel in the modulation of neuron survival elicited by glutamate and interleukin- 1beta. J. Biol. Chem. 277, 20717-20723.
65. Pohl, T., Gugasyan, R., Grumont, R. J., Strasser, A., Metcalf, D., Tarlinton, D., Sha, W., Baltimore, D. and Gerondakis, S. (2002) The combined absence of NF-kappa B1 and c-Rel reveals that overlapping roles for these transcription factors in the B cell lineage are restricted to the activation and function of mature cells. Proc. Natl .Acad. Sci. USA 99, 4514-4519.
66. Poljak, L., Carlson, L., Cunningham, K., Kosco-Vilbois, M. H. and Siebenlist, U. (1999) Distinct activities of p52/NF-kappa B required for proper secondary lymphoid organ microarchitecture: functions enhanced by Bcl-3. J. Immunol. 163, 6581-6588.
67. Sanjabi, S., Hoffmann, A., Liou, H. C., Baltimore, D. and Smale, S. T. (2000) Selective requirement for c-Rel during IL-12 P40 gene induction in macrophages. Proc. Natl. Acad. Sci. USA 97, 12705-12710.
68. Scheinman, R. I., Beg, A. A. and Baldwin, A. S., Jr. (1993) NF-kappa B p100 (Lyt-10) is a component of H2TF1 and can function as an I kappa B-like molecule.
69. Schneider, A., Martin-Villalba, A., Weih, F., Vogel, J., Wirth, T. and Schwaninger, M. (1999) NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat. Med. 5, 554-559.
70. Sen, R. and Baltimore, D. (1986) Indicibility of k immunoglobulin enahncer-binding protein NF-κB by a posttranslational mechanism. Cell 47, 921-928.
71. Senftleben, U., Cao, Y., Xiao, G., Greten, F. R., Krahn, G., Bonizzi, G., Chen, Y., Hu, Y., Fong, A., Sun, S. C. and Karin, M. (2001) Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science. 293, 1495-1499.
72. Sha, W. C., Liou, H.-C., Tuomanen, E. I. and Baltimore, D. (1995) Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80, 321-330.
73. Smith, K. A. (1986) Interleukin-2:inception, impact, and implications. Science 240, 1169-1176.
74. Snapper, C. M., Rosas, F. R., Zelazowski, P., Moorman, M. A., Kehry, M. R., Bravo, R. and Weih, F. (1996) B cells lacking RelB are defective in proliferative responses, but undergo normal B cell maturation to Ig secretion and Ig class switching. J. Exp. Med. 184, 1537-1541.
75. Snapper, C. M., Zelazowski, P., Rosas, F. R., Kehry, M. R., Tian, M., Baltimore, D. and Sha, W. C. (1996) B cells from p50/NF-kappa B knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching. J. Immunol. 156, 183-191.
76. Solvason, N., Wu, W. W., Kabra, N., Lund-Johansen, F., Roncarolo, M. G., Behrens, T. W., Grillot, D. A., Nunez, G., Lees, E. and Howard, M. (1998) Transgene expression of bcl-xL permits anti-immunoglobulin (Ig)-induced proliferation in xid B cells. J. Exp. Med. 187, 1081-1091.
77. Sproul, T. W., Malapati, S., Kim, J. and Pierce, S. K. (2000) Cutting edge: B cell antigen receptor signaling occurs outside lipid rafts in immature B cells. J. Immunol. 165, 6020-6023.
78. Su, T. T., Guo, B., Kawakami, Y., Sommer, K., Chae, K., Humphries, L. A., Kato, R. M., Kang, S., Patrone, L., Wall, R., Teitell, M., Leitges, M., Kawakami, T. and Rawlings, D. J. (2002) PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signaling. Nat. Immunol. 3, 780-786.
79. Sun, Z., Arendt, C. W., Ellmeier, W., Schaeffer, E. M., Sunshine, M. J., Gandhi, L., Annes, J., Petrzilka, D., Kupfer, A., Schwartzberg, P. L. and Littman, D. R. (2000) PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes. Nature 404, 402-407.
80. Suzuki, H., Terauchi, Y., Fujiwara, M., Aizawa, S., Yazaki, Y., Kadowaki, T. and Koyasu, S. (1999) Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase. Science 283, 390-392.
81. Tam, W. F., Lee, L. H., Davis, L. and Sen, R. (2000) Cytoplasmic sequestration of Relproteins by IκB-alpha requires CRM1-dependent nuclear export. Mol. Cell. Biol. 20, 2269-2284.
82. Tam, W. F. and Sen, R. (2001) IκB family members function by different mechanisms. J. Biol. Chem. 276, 7701-7704.
83. Tam, W. F., Wang, W. and Sen, R. (2001) Cell-specific association and shuttlingof IκB-alpha provides a mechanism for nuclear NF-κB in B lymphocytes. Mol. Cell. Biol. 21, 4837-4846.
84. Tumang, J. R., Owyang, A., Andjelic, S., Jin, Z., Hardy, R. R., Liou, M.-L. and Liou, H.-C. (1998) C-Rel is essential for B lymphocyte survival and cell cycle progression. Eur. J. Immunol. 28, 4299-4312.
85. Villalba, M., Bi, K., Hu, J., Altman, Y., Bushway, P., Reits, E., Neefjes, J., Baier, G., Abraham, R. T. and Altman, A. (2002) Translocation of PKC(theta) in T cells is mediated by a nonconventional, PI3-K- and Vav-dependent pathway, but does not absolutely require phospholipase C. J. Cell Biol. 157, 253-263.
86. Wagner, H. (2002) Interactions between bacterial CpG-DNA and TER9 bridge innate and adaptive immunity. Curr. Opin. Microbiol. 5, 62-69.
87. Wang, C.-Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V. and Baldwin, A. S. (1998) NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281, 680-683.
88. Weih, F., Durham, S. K., Barton, D. S., Sha, W. C., Baltimore, D. and Bravo, R. (1997) p50-NF-kappaB complexes partially compensate for the absence of RelB: severely increased pathology in p50(-/-)relB(-/-) double-knockout mice. J. Exp. Med. 185, 1359-1370.
89. Weinmann, A. S., Mitchell, D. M., Sanjabi, S., Bradley, M. N., Hoffmann, A., Liou, H. C. and Smale, S. T. (2001) Nucleosome remodeling at the IL-12 p40 promoter is a TLR-dependent, Rel- independent event. Nat. Immunol. 2, 51-57.
90. Wu, L., D'Amico, A., Winkel, K. D., Suter, M., Lo, D. and Shortman, K. (1998) RelB is essential for the development of myeloid-related CD8alpha- dendritic cells but not of lymphoid-related CD8alpha+ dendritic cells. Immunity 9, 839-847.
91. Yang, H., Thomas, D., Boffa, D. J., Ding, R., Li, B., Muthukumar, T., Sharma, V. K., Lagman, M., Luo, G. X., Kapur, S., Liou, H. C., Hancock, W. W. and Suthanthiran, M. (2002) Enforced c-REL deficiency prolongs survival of islet allografts1. Transplantation 74, 291-298.
92. Yang, L., Cohn, L., Zhang, D. H., Homer, R., Ray, A. and Ray, P. (1998) Essential role of nuclear factor kappaB in the induction of eosinophilia in allergic airway inflammation. J. Exp. Med. 188, 1739-1750.
93. Yankee, T. M. and Clark, E. A. (2000) Signaling through the B cell antigen receptor in developing B cells. Rev. Immunogenet. 2, 185-203.
94. Zandi, E., Chen, Y. and Karin, M. (1998) Direct phosphorylation of IkappaB by IKKalpha and IKKbeta: discrimination between free and NF-kappaB-bound substrate. Science 281, 1360-1363.
95. Zheng, Y., Ouaaz, F., Bruzzo, P., Singh, V., Gerondakis, S. and Beg, A. A. (2001) NF-kappa B RelA (p65) is essential for TNF-alpha-induced fas expression but dispensable for both TCR-induced expression and activation-induced cell death. J. Immunol. 166, 4949-4957.
96. Zong, W.-X., Edelstein, L. C., Chen, C., Bash, J. and Gelinas, C. (1999) The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNF-induced apoptosis. Genes & Dev. 13, 382-387.